Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Polarized Reflectance Spectroscopy for Detection of High-risk Oral Lesions

NCT01604759 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT01604759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01604759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Polarized Reflectance Spectroscopy for Detection of High-risk Oral Lesions
Lead sponsor
British Columbia Cancer Agency
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2011
Completion date
December 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral cancer